HOME >> MEDICINE >> NEWS
Bayer launches Phase III clinical study of Trasylol in elective spinal fusion surgery

Bayer Pharmaceuticals Corporation (NYSE: BAY) today announced the initiation of a Phase III clinical trial to evaluate the safety and efficacy of Trasylol (aprotinin injection) in reducing blood loss and the need for transfusion in adult patients undergoing elective spinal fusion surgery.

Spinal fusion surgery involves 'fusing' together one or more of the small bones of the spine with bone grafts and devices. This fusion limits the motion between the vertebrae allowing surgeons to treat injuries to the spine, repair broken vertebra, correct deformities, adjust abnormal curvatures, stabilize weakness and remedy slipped or herniated disks. Approximately 300,000 spinal fusion surgeries take place each year in the United States, a figure that has doubled in the last decade (1).

Patients undergoing spinal fusion surgery are subject to a blood transfusion rate that may be six times greater than that of patients undergoing spinal surgery without fusion (2). Spine fusion surgery is also associated with more complications (such as infection, chronic pain and neural injuries) as it requires more extensive dissection and longer operative time (3).

"Blood loss can be a significant complication of spine surgery. Combined with the potential health risks associated with transfusions and the rising cost of blood products, there is a great need to reduce bleeding in this surgical setting," said Michael Neuwirth, MD, lead investigator of the study and director of the Spine Institute at Beth Israel Medical Center. "Trasylol has been proven safe and effective in reducing blood loss and transfusion requirements in coronary artery bypass surgery, and we are studying the drug to determine if it may play a similar role in spinal fusion surgery."

The multi-center, randomized, double-blind, placebo-controlled trial will assess the ability of Trasylol to reduce bleeding and the need for blood transfusions in elective spinal fusion surgery involving three
'"/>


8-Dec-2005


Page: 1 2

Related medicine news :

1. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
2. Worlds largest respiratory health study launches next phase
3. Elsevier launches the Clinics on ScienceDirect
4. Elsevier launches Molecular Oncology
5. Kennedy Krieger Institute launches first national online autism registry
6. UW launches study testing adult stem cells for heart damage repair
7. IEEE-USA launches critical infrastructure protection committee
8. Liverpool launches 20 million project to develop medicines for children
9. ESSP launches project on the effects of global environmental change on human health
10. ACP re-launches magazine for hospitalists
11. The Starr Foundation launches multi-institutional cancer consortium

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2019)... ... ... Ovation® Fertility scientists have been invited to present four pieces of research at ... in Vienna, June 23-26, 2019. , Ovation’s oral presentation about the use of artificial ... for Oral Presentation and the Fertility Society of Australia Exchange Award., ...
(Date:6/18/2019)... ... June 18, 2019 , ... Cosmetic Town, an online ... of cosmetic facial rejuvenation in June. The Cosmetic Town website will showcase cosmetic ... performing various methods of cosmetic facial rejuvenation and videos that take viewers behind ...
(Date:6/18/2019)... ... June 18, 2019 , ... NeoTract, a wholly ... field of urology, today announced that Aaron Berger, MD, Associated Urological Specialists, LLC ... designation recognizes that Dr. Aaron Berger has achieved a high level of training ...
(Date:6/16/2019)... NEWPORT BEACH, Calif. (PRWEB) , ... June 14, ... ... Data Protection / Cyber Security solutions, today announced it has received the ... showcasing the award winning DLP that Works Platform along with the latest additions ...
(Date:6/16/2019)... SPRINGFIELD, Mo. (PRWEB) , ... June 15, 2019 , ... ... Convoy of Hope has been committed to helping those in need around the world. ... people in more than 125 countries. Convoy’s work would not be possible without the ...
Breaking Medicine News(10 mins):
(Date:6/24/2019)... ... June 24, 2019 , ... The Conference Forum has announced ... place on September 17-18, 2018 at the Renaissance Waterfront Hotel in Boston, MA, with ... Scott Gottlieb, 23rd Commissioner of the FDA, has chosen DPharm to deliver his perspective ...
(Date:6/24/2019)... ... 24, 2019 , ... Enespro PPE , a manufacturer ... the electrical industry has today announced the release of its guide for companies ... Developing a Culture of Electrical Safety, is written to address the continued challenge ...
(Date:6/20/2019)... ... , ... ERT, a global data and technology company that ... experts will present a series of innovative and educational live sessions and posters ... Diego, June 23-27. , ERT’s industry-recognized thought leaders will share their knowledge on ...
Breaking Medicine Technology:
Cached News: